NASDAQ: GNPX       Genprex Inc
Last Price Today's Change   Day's Range   Trading Volume
3.62   +0.01 (0.28%)  3.53 - 3.75  373,300


Avg Volume (4 weeks):985,365
4 Weeks Range:3.46 - 4.47
4 Weeks Price Volatility (%):
52 Weeks Range:0.23 - 7.03
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Genprex Inc is a US-based clinical stage gene therapy company. It is engaged in developing a new approach to treating cancer, based upon its novel proprietary technology platform, including initial product candidate, Oncoprex immunogene therapy. The company's lead product candidate is Oncoprex, which has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis in cancer cells, and modulates the immune response against cancer cells. Genprex is conducting preclinical research for developing Oncoprex to be administered with immunotherapies in non-small cell lung cancer as well as into other tumor suppressor genes.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

4121  4238  549  164 

Top 10 Active Counters
 NAOV 1.20+0.61 
 AAPL 111.81+1.73 
 GE 6.25-0.10 
 XLF 23.73-0.20 
 TSLA 424.23-25.16 
 SQQQ 25.62-1.49 
 BAC 23.94-0.53 
 SPY 330.30+3.33 
 NIO 19.23+0.42 
 SRNE 10.78+1.025